EA201790855A1 - Трансдермальная терапевтическая система с высокой адгезивной способностью - Google Patents

Трансдермальная терапевтическая система с высокой адгезивной способностью

Info

Publication number
EA201790855A1
EA201790855A1 EA201790855A EA201790855A EA201790855A1 EA 201790855 A1 EA201790855 A1 EA 201790855A1 EA 201790855 A EA201790855 A EA 201790855A EA 201790855 A EA201790855 A EA 201790855A EA 201790855 A1 EA201790855 A1 EA 201790855A1
Authority
EA
Eurasian Patent Office
Prior art keywords
therapeutic system
transdermal therapeutic
high adhesive
adhesive ability
ability
Prior art date
Application number
EA201790855A
Other languages
English (en)
Other versions
EA034204B1 (ru
Inventor
Джованни ДЖЕННАРИ
Анна Мария Дзанеллато
Патриция Санти
Кристина Падула
Original Assignee
Фидия Фармачеутичи С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фидия Фармачеутичи С.П.А. filed Critical Фидия Фармачеутичи С.П.А.
Publication of EA201790855A1 publication Critical patent/EA201790855A1/ru
Publication of EA034204B1 publication Critical patent/EA034204B1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Настоящее изобретение относится к высокоадгезивной трансдермальной терапевтической системе, содержащей адгезивную полимерную матрицу с солью диклофенака.
EA201790855A 2014-10-17 2015-10-15 Дермальная терапевтическая система с высокой адгезивной способностью EA034204B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI20141803 2014-10-17
PCT/IB2015/057913 WO2016059583A1 (en) 2014-10-17 2015-10-15 Dermal therapeutic system with high adhesivity

Publications (2)

Publication Number Publication Date
EA201790855A1 true EA201790855A1 (ru) 2017-08-31
EA034204B1 EA034204B1 (ru) 2020-01-16

Family

ID=51951915

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201790855A EA034204B1 (ru) 2014-10-17 2015-10-15 Дермальная терапевтическая система с высокой адгезивной способностью

Country Status (4)

Country Link
US (2) US9962349B2 (ru)
EP (1) EP3206673B1 (ru)
EA (1) EA034204B1 (ru)
WO (1) WO2016059583A1 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7453994B2 (ja) * 2019-04-17 2024-03-21 エルテーエス ローマン テラピー-ジステーメ アーゲー 経皮治療システム
US11752114B2 (en) * 2019-04-17 2023-09-12 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system
IT202000011686A1 (it) 2020-05-20 2021-11-20 Fidia Farm Spa Cerotto medicato a lento rilascio

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928666A (en) * 1996-11-12 1999-07-27 Cygnus Inc. Crystalline form of estradiol and pharmaceutical formulations comprising same
US6193996B1 (en) * 1998-04-02 2001-02-27 3M Innovative Properties Company Device for the transdermal delivery of diclofenac
DE19918105C1 (de) * 1999-04-22 2000-09-21 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einem stark wirksamen Neuroleptikum
DE19950066A1 (de) * 1999-10-16 2001-04-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einem Gehalt an Tulobuterol-hydrochlorid zur Verabreichung des Bronchodilatators Tulobuterol über die Haut
US20040146548A1 (en) * 2001-05-31 2004-07-29 Yasunori Takada Percutaneously absorbable patches
ITMI20041628A1 (it) 2004-08-06 2004-11-06 Bouty S P A Sistema terapeutico a rilascio controllato per uso topico transdermico
KR100929560B1 (ko) * 2008-01-09 2009-12-03 에코 퍼시픽 엘티디 그라니세트론을 함유한 매트릭스 형태의 경피 흡수제
KR20110097829A (ko) * 2008-11-14 2011-08-31 포톨라 파마슈티컬스, 인코포레이티드 낮은 pH에서 불량한 수용해도를 갖는 이온화가능한 활성제의 제어 방출을 위한 고체 조성물, 및 그의 사용 방법
IT1397246B1 (it) 2009-05-14 2013-01-04 Fidia Farmaceutici Nuovi medicamenti ad uso topico a base di acido ialuronico solfatato come agente attivante o inibente l'attivita' citochinica
NZ602274A (en) * 2010-04-30 2014-05-30 Teikoku Pharma Usa Inc Propynylaminoindan transdermal compositions
WO2012087749A1 (en) * 2010-12-20 2012-06-28 Polytherapeutics, Inc. Composition for transdermal administration of non-steroidal anti-inflammatory drug
ITMI20111355A1 (it) * 2011-07-20 2013-01-21 Epifarma Srl Cerotto transdermico contenente diclofenac e tiocolchicoside
WO2014012653A1 (en) * 2012-07-16 2014-01-23 Grünenthal GmbH Pharmaceutical patch for transdermal administration of tapentadol

Also Published As

Publication number Publication date
EP3206673A1 (en) 2017-08-23
US10478413B2 (en) 2019-11-19
EA034204B1 (ru) 2020-01-16
US20170231936A1 (en) 2017-08-17
US9962349B2 (en) 2018-05-08
US20180153836A1 (en) 2018-06-07
WO2016059583A1 (en) 2016-04-21
EP3206673B1 (en) 2024-08-21

Similar Documents

Publication Publication Date Title
EA201891209A1 (ru) Модуляторы хемокиновых рецепторов
MY167716A (en) Drive device
DK3108199T3 (da) Ballistisk hjelm
CL2014003040S1 (es) Carcasa para autoinyector.
BR112016029076A2 (pt) modulação de atividade de complemento
DK3352625T3 (da) Reorganiserbar liggestol til flere formål, flere anvendelser
ECSP17015977A (es) Terapia de combinacion
DK3532772T3 (da) Strømforsyningssystem.
DK3171701T3 (da) Infusionsanlæg
BR112017013156A2 (pt) combinações de composto ativo.
EA201700142A1 (ru) Полимерная композиция для слоя элемента слоя
BR112017012801A2 (pt) combinações de composto ativo.
DK3629026T3 (da) Midler, der modulerer gastrointestinale smerter
FR3023171B1 (fr) Autoinjecteur.
BR112018012116A2 (pt) terapia intravesical para câncer de bexiga
EA201790855A1 (ru) Трансдермальная терапевтическая система с высокой адгезивной способностью
BR112017002139A2 (pt) ?método para preparar um composto?
DE112014006249A5 (de) Hydrostatisch betätigtes Kupplungssystem
FR3023170B1 (fr) Autoinjecteur.
DK3795130T3 (da) Terapiapparat.
DE112015000742A5 (de) Kupplungsplatte
DK2921760T3 (da) Afstandsstykke.
ITUA20161552A1 (it) Riflettore modulante per fondo pozzo
DK2996288T3 (da) Ikke-bevaret meddelelsessystem
ECSP19015143A (es) Compuestos de tiazolo-piridina sustituida como inhibidores de malt1

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM KZ KG TJ TM